Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 2 1Phase 1/2 1Phase 1 1

Status

Completed 3Withdrawn 1

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Other neoplasm 4Head & Neck 1Gastrointestinal 1Dermatologic 1

Conditions

Colorectal Neoplasms 26Breast Neoplasms 21Carcinoma, Non-Small-Cell Lung 19Lung Neoplasms 15Head and Neck Neoplasms 13Rectal Neoplasms 11Colonic Neoplasms 11Prostatic Neoplasms 8Pancreatic Neoplasms 7Mouth Neoplasms 6Glioblastoma 6Neuroblastoma 5Neoplasm Metastasis 5Esophageal Neoplasms 5Central Nervous System Neoplasms 5Carcinoma 5Unspecified Adult Solid Tumor, Protocol Specific 4Triple Negative Breast Neoplasms 4Recurrence 4Precancerous Conditions 4Ovarian Neoplasms 4Oropharyngeal Neoplasms 4Neoplasms 4Liver Neoplasms 4Laryngeal Neoplasms 4Hypopharyngeal Neoplasms 4Gliosarcoma 4Carcinoma, Hepatocellular 4Adenomatous Polyposis Coli 4Sarcoma 3

Interventions

Whole-Body Irradiation 6Peripheral Blood Stem Cell Transplantation 6Biopsy 6fludarabine phosphate 5Immunohistochemistry 5Epoetin Alfa 5Cyclophosphamide 5Tacrolimus 4Methotrexate 4Gene Expression Profiling 4Celecoxib 4Mycophenolic Acid 3Microarray Analysis 3Imiquimod 3Etoposide 3Darbepoetin alfa 3Cyclosporine 3Colposcopy 3Busulfan 3Antilymphocyte Serum 3Aminolevulinic Acid 3Tomography, Optical Coherence 2Sirolimus 2Polymerase Chain Reaction 2Methylprednisolone 2Melphalan 2Mass Spectrometry 2Immunoenzyme Techniques 2Filgrastim 2Fatty Acids, Omega-3 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × Precancerous Conditions × Celecoxib × Clear all
NCT00685568 2018-11-07

Celecoxib in Preventing Colorectal Cancer in Young Patients With a Genetic Predisposition for Familial Adenomatous Polyposis

M.D. Anderson Cancer Center

Phase 1 Completed
22 enrolled
GastrointestinalOther neoplasm

Colonic Neoplasms, Adenomatous Polyposis Coli, Precancerous Conditions, Rectal Neoplasms, Colorectal Neoplasms

NCT00314262 2014-10-24

Phase I/II Study of Chemoprevention With EGFR and COX-2 Inhibitor

Emory University

Phase 1/2 Completed
17 enrolled 7 charts
Other neoplasm

Precancerous Conditions

NCT00027976 2013-08-05

Celecoxib in Preventing Skin Cancer in Patients With Actinic Keratoses

University of Alabama at Birmingham

Phase 2/3 Withdrawn
DermatologicOther neoplasm

Precancerous Conditions, Keratosis, Actinic

NCT00101335 2013-07-11

Celecoxib in Preventing Head and Neck Cancer in Patients With Oral Leukoplakia

Fox Chase Cancer Center

Phase 2 Completed
Head & NeckOther neoplasm

Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Leukoplakia, Oral, Mouth Neoplasms, Nasopharyngeal Neoplasms, Oropharyngeal Neoplasms, Precancerous Conditions, Tongue Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡